<DOC>
	<DOCNO>NCT02706743</DOCNO>
	<brief_summary>The aim study assess impact adjuvant radioactive iodine therapy quality life ( QOL ) differentiate thyroid cancer patient identify independent factor affect change QOL .</brief_summary>
	<brief_title>Assessment Quality Life After Adjunct Radioiodine Therapy Patients With Differentiated Thyroid Cancer</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>Pathologically confirm new diagnosis differentiate thyroid cancer , recently treat total thyroidectomy Must sign consent form treatment One year followup radioiodine ablation Patients follicular , HÃ¼rthle cell , poorly differentiate , medullary , anaplastic thyroid carcinoma Pregnant lactate woman Patients receive adjuvant radioiodine treatment past Patients cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>